NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1994
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Iobenguane sulfate I-131 is a radioiodinated norepinephrine analog administered by injection for diagnostic and therapeutic imaging of neuroendocrine tumors. It localizes to catecholamine-producing tissues and is used to identify and stage pheochromocytomas and paragangliomas. The mechanism relies on uptake via norepinephrine transporters in sympathetic nerve tissue.
LOE Approaching
Product is in late lifecycle with moderate competitive pressure (30), suggesting defensive positioning and focus on retention rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on this product offers exposure to specialized nuclear medicine and radiopharmaceutical market dynamics, but with zero linked job openings suggests limited team expansion. Career progression may depend on defending market share against emerging technologies rather than launching growth initiatives.
Brand ManagerMedical Science Liaison
Worked on IOBENGUANE SULFATE I 131 at PharmaLundensis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.